AscomHQ Switzerland · Europe
Clinical communications & nurse call
FY2025 revenue CHF 292.1m (+1.9%); operating margin 6.9%; net income CHF 15.1m.
No debt; CHF 29.6m cash.
Financial health: FairRisk summary →
No reviews yet
View profileAll suppliers
Showing 1–7 of 7 · Clinical communications & nurse call
AustcoHQ Australia · Asia-Pacific
Clinical communications & nurse call
FY2026 revenue A$94.2m (+16.0%); net margin 9.6%; net income A$9.0m.
EBITDA A$14.9m (+14%); NPAT up 52%.
Financial health: FairRisk summary →
No reviews yet
View profileNervecentreHQ United Kingdom · Europe
Clinical communications & nurse callElectronic health records (EHR/EPR)Patient flow & operations
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profileRaulandHQ United States · North America
Clinical communications & nurse call
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
Financial health: Not assessedRisk summary →
No reviews yet
View profileSpokHQ United States · North America
Clinical communications & nurse call
FY2025 revenue $139.7m (+1.5%); operating margin 14.1%; net income $15.9m.
No debt; $25.3m cash.
Financial health: StrongRisk summary →
No reviews yet
View profileStrykerHQ United States · North America
Clinical communications & nurse callMedical devices & monitoringSurgical & theatre systems
FY2025 revenue $25.12bn (+11.2%); operating margin 19.5%; net income $3.25bn.
Balance sheet figures not captured from release.
Financial health: StrongRisk summary →
No reviews yet
View profileTigerConnectHQ United States · North America
Clinical communications & nurse call
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profile